Journal of Antimicrobial Chemotherapy logo Oxford University Press logo

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.

Publisher: Oxford University Press

Volume 54, Number 6, December 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy
pp. 971-981(11)
Authors: T. S. J. Elliott; J. Foweraker; F. K. Gould; J. D. Perry; J. A. T. Sandoe

The intracellular pharmacology of antiretroviral protease inhibitors
pp. 982-990(9)
Authors: J. Ford; S. H. Khoo; D. J. Back

Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance
pp. 991-998(8)
Authors: Andrea Brenciani; Kayode K. Ojo; Alessia Monachetti; Stefano Menzo; Marilyn C. Roberts; Pietro E. Varaldo; Eleonora Giovanetti

Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
pp. 999-1006(8)
Authors: Masakazu Niimi; Kyoko Niimi; Yukie Takano; Ann R. Holmes; Frank J. Fischer; Yoshimasa Uehara; Richard D. Cannon

Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals
pp. 1007-1012(6)
Authors: Jing-Jou Yan; Jiunn-Jong Wu; Wen-Chien Ko; Shu-Huei Tsai; Chin-Luan Chuang; Hsiu-Mei Wu; Ying-Jiun Lu; Jau-Dai Li

Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system
pp. 1013-1018(6)
Authors: Shawn Rossi; Ali O. Azghani; Abdelwahab Omri

Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?
pp. 1019-1024(6)
Authors: Franck Furno; Kelly S. Morley; Ben Wong; Barry L. Sharp; Polly L. Arnold; Steven M. Howdle; Roger Bayston; Paul D. Brown; Peter D. Winship; Helen J. Reid

Antimicrobial resistance in Campylobacter strains isolated from French broilers before and after antimicrobial growth promoter bans
pp. 1025-1030(6)
Authors: Marie-Hélène Desmonts; Fabienne Dufour-Gesbert; Laetitia Avrain; Isabelle Kempf

Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece
pp. 1031-1034(4)
Authors: Petros Kalocheretis; Eleftheria Baimakou; Sinodi Zerbala; Joseph Papaparaskevas; Ioanna Makriniotou; Panayotis T. Tassios; Christos Iatrou; Evangelia Kouskouni; Loukia Zerva

Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14
pp. 1035-1039(5)
Authors: Ricardo Dias; Manuela Caniça

A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand
pp. 1040-1044(5)
Authors: Brigitte Malbruny; Anja M. Werno; Trevor P. Anderson; David R. Murdoch; Roland Leclercq

Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe
pp. 1045-1050(6)
Authors: Nienke Bruinsma; Karl G. Kristinsson; Stef Bronzwaer; Paul Schrijnemakers; John Degener; Edine Tiemersma; Waleria Hryniewicz; Jos Monen; on behalf of EARSS participants

Initial results from a longitudinal international surveillance programme for anidulafungin (2003)
pp. 1051-1056(6)
Authors: Shawn A. Messer; Jeffrey T. Kirby; Helio S. Sader; Thomas R. Fritsche; Ronald N. Jones

Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients
pp. 1057-1061(5)
Authors: Michael Hogardt; Sabine Schmoldt; Monika Götzfried; Kristin Adler; Jürgen Heesemann

Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens
pp. 1062-1066(5)
Authors: Inga Odenholt; Otto Cars; Elisabeth Löwdin

Pulsatile delivery of amoxicillin against Streptococcus pneumoniae
pp. 1067-1071(5)
Authors: Raymond Cha; Michael J. Rybak

Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations
pp. 1072-1077(6)
Authors: George G. Zhanel; Christel Johanson; Tamiko Hisanaga; Chris Mendoza; Nancy Laing; Ayman Noreddin; Aleksandra Wierzbowski; Daryl J. Hoban

In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model
pp. 1078-1084(7)
Authors: Christopher Faber; Roel J. W. Hoogendoorn; Hein P. Stallmann; D. M. Lyaruu; Arie van Nieuw Amerongen; on behalf of STEGA Skeletal Tissue Engineering Group Amsterdam

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
pp. 1085-1091(7)
Authors: Abelardo Montero; Javier Ariza; Xavier Corbella; Alejandro Doménech; Carmen Cabellos; Josefina Ayats; Fe Tubau; Carmen Borraz; Francesc Gudiol

A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B
pp. 1092-1095(4)
Authors: Javier Capilla; Emilio Mayayo; Carolina Serena; F. Javier Pastor; Josep Guarro

Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis
pp. 1096-1102(7)
Authors: Jill P. Adler-Moore; Jon A. Olson; Richard T. Proffitt

Treatment of experimental osteomyelitis by liposomal antibiotics
pp. 1103-1108(6)
Authors: Ashraf A. Kadry; Saleh A. Al-Suwayeh; Adel R. A. Abd-Allah; Mohsen A. Bayomi

Reduced colonization and infection with miconazole–rifampicin modified central venous catheters: a randomized controlled clinical trial
pp. 1109-1115(7)
Authors: Nedim Yücel; Rolf Lefering; Marc Maegele; Martin Max; Rolf Rossaint; Andrea Koch; Rosemarie Schwarz; Michael Korenkov; Josef Beuth; Alfons Bach; Jörg Schierholz; Gerhard Pulverer; Edmund A. M. Neugebauer

Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities
pp. 1116-1121(6)
Authors: Annemiek E. Akkerman; Johannes C. van der Wouden; Marijke M. Kuyvenhoven; Jeanne P. Dieleman; Theo J. M. Verheij

Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001
pp. 1122-1126(5)
Authors: Berit Müller-Pebody; Mark Muscat; Benjamin Pelle; Bjarke M. Klein; Christian T. Brandt; Dominique L. Monnet

Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus
pp. 1127-1129(3)
Authors: Alexander John O'Neill; Keith Miller; Brunello Oliva; Ian Chopra

Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase
pp. 1130-1133(4)
Authors: Cheol-In Kang; Hyunjoo Pai; Sung-Han Kim; Hong-Bin Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe

Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents
pp. 1134-1138(5)
Authors: F. M. Thibault; E. Hernandez; D. R. Vidal; M. Girardet; J.-D. Cavallo

Antimicrobial susceptibility of Haemophilus influenzae strains isolated from invasive disease in Italy
pp. 1139-1143(5)
Authors: Marina Cerquetti; Rita Cardines; Maria Giufrè; Paola Mastrantonio; on behalf of the Hi Study Group

Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital
pp. 1144-1147(4)
Authors: Ja-Young Kim; Yeon-Joon Park; Sang-Il Kim; Moon Won Kang; Seung-Ok Lee; Kyo-Young Lee

Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation
pp. 1148-1151(4)
Authors: David Sevillano; Almudena Calvo; María-José Giménez; Luis Alou; Lorenzo Aguilar; Eva Valero; Antonio Carcas; José Prieto

Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children
pp. 1152-1154(3)
Authors: Alina S. Bergshoeff; Pieter L. A. Fraaij; Corrien Verweij; Annemarie M. C. van Rossum; Gwenda Verweel; Nico G. Hartwig; Ronald de Groot; David M. Burger

Is it safe to use carbapenems in patients with a history of allergy to penicillin?
pp. 1155-1157(3)
Authors: Manica Sodhi; Sandra S. Axtell; Joyce Callahan; Raja Shekar

Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections
pp. 1158-1158(1)
Authors: Frédéric Frippiat; Françoise Meunier; Geneviève Derue

IMP-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa in a university hospital in the People's Republic of China
pp. 1159-1160(2)
Authors: Chun-xin Wang; Zu-huang Mi

Treatment of Gram-positive bone and joint infection: authors' response
pp. 1159-1159(1)
Authors: Elizabeth S. R. Darley; Alasdair P. MacGowan

DNA Amplification: Current Technologies and Applications
pp. 1161-1161(1)
Author: Peter V. Coyle

Management of Multiple Drug-Resistant Infections
pp. 1162-1162(1)
Author: David M. Livermore

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A